Europe Glycomics Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product (Enzymes, Instruments, Kits, and Reagents), Application (Drug Discovery and Development, Diagnostics, Immunology, Cancer, and Others), and End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, and Contract Research Organizations)

BMIRE00027257 | Pages: 195 | Biotechnology | Oct 2022 | Type: Regional | Status: Published

The Europe glycomics market is expected to grow from US$ 428.99 million in 2022 to US$ 899.30 million by 2028; it is estimated to grow at a CAGR of 13.1% from 2022 to 2028.

 

 

 Glycomics is the study of glycans or sugar structures found in the human body. These glycans, which may be exceedingly complex, are found in many microbiome components, such as proteins and cell surfaces. Researchers and players are actively involved in the glycomics industry and are constantly focusing on advancing technologies that can offer better alternatives to conventional techniques. For instance, in June 2018, the LCMS-9030 Quadrupole Time of Flight (Q-TOF) mass spectrometry (MS) system with informatics support—powered by PREMIER Biosoft's software solutions for lipidomics and glycomics data analysis—was introduced by Shimadzu and PREMIER Biosoft, which provides bioinformatics solutions to life sciences laboratories. Shimadzu and PREMIER Biosoft have partnered with an objective to improve lipidomics and glycomics research. Further, in June 2022, Thermo Fisher Scientific Inc. and TransMIT GmbH Center for Mass Spectrometric Developments established a co-marketing partnership to promote the use of mass spectrometry imaging (MSI) technology for spatial multi-omics applications in pharma and clinical laboratories. This instrument can be used for omics applications, such as pharmaco-kinetic research in various tissues, metabolomics, lipidomics, proteomics, and glycomics. These advancements are propelling the glycomics market significantly.

 

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the Europe glycomics market. The Europe glycomics market is expected to grow at a good CAGR during the forecast period. 

 

 Europe Glycomics Market Revenue and Forecast to 2028 (US$ Million)  

Get more information on this report :

 

 

 

Europe Glycomics Market Segmentation         

 

The Europe glycomics market is segmented based on product, application, end user, and country. Based on product, the Europe glycomics market is segmented into enzymes, instruments, kits, and reagents. The enzymes segment dominated the market in 2022. The enzymes segment is further segmented into glycosidases, glycosyl transferases, sialyltransferases, neuraminidases, and others. The instruments segment is also segmented into mass spectrometers, MALDI-TOF, HPLC, lectin arrays, antibody arrays, and others. Similarly, the kits segment is segmented into glycan release kits, glycan labeling kits, glycan purification kits, and others. Furthermore, the reagents segment is segmented into oligosaccharides, monosaccharides, glycoproteins, and others. Based on application, the Europe glycomics market is segmented into drug discovery and development, diagnostics, immunology, cancer, and others. The drug discovery and development segment dominated the market in 2022. Based on end user, the Europe glycomics market is segmented into pharmaceutical & biotechnology companies, academic & research institutes, and contract research organizations. The pharmaceutical & biotechnology companies segment dominated the market in 2022. Based on country, the Europe glycomics market has been categorized into the UK, Germany, France, Italy, Spain, and the Rest of Europe. Germany dominated the market in 2022.

 

Agilent Technologies, Inc.; Asparia Glycomics; Bruker Corporation; MERCK KGaA; New England Biolabs; S-BIO (Sumitomo Bakelite Co., Ltd.); Shimadzu Corporation; Takara Bio Inc.; Thermo Fisher Scientific Inc.; and Waters Corporation are among the leading companies in the Europe glycomics market.     

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        Europe Glycomics Market – By Product

1.3.2        Europe Glycomics Market – By Application

1.3.3        Europe Glycomics Market – By End User

1.3.4        Europe Glycomics Market – By Country

2.           Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           Europe Glycomics Market – Market Landscape

4.1         Overview

4.2         Europe PEST Analysis

4.3         Expert Opinion

5.           Europe Glycomics Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Increased Glycomics Research and Expanding R&D Investments

5.1.2        Rising Use of Glycomics in Various Diseases Leading to Development of New Treatment Processes

5.2         Market Restraints

5.2.1        High Cost of Equipment and Shortage of skilled Professionals

5.3         Market Opportunities

5.3.1        Wide Applications of Glycomics

5.4         Future Trends

5.4.1        New tools in Glycomics Research

5.5         Impact Analysis

6.           Glycomics Market– Europe Analysis

6.1         Europe Glycomics Market Revenue Forecast and Analysis

7.           Europe Glycomics Market Analysis – By Product

7.1         Overview

7.2         Europe Glycomics Market, By Product 2022 & 2028 (%)

7.3         Enzymes

7.3.1        Overview

7.3.2        Enzymes Revenue and Forecast to 2028 (US$ Million)

7.3.3        Glycosidases

7.3.3.1          Overview

7.3.3.2          Glycosidases - Revenue and Forecast to 2028 (US$ Million)

7.3.4        Glycosyltransferases

7.3.4.1          Overview

7.3.4.2          Glycosyltransferases - Revenue and Forecast to 2028 (US$ Million)

7.3.5        Sialyltransferases

7.3.5.1          Overview

7.3.5.2          Sialyltransferases - Revenue and Forecast to 2028 (US$ Million)

7.3.6        Neuraminidases

7.3.6.1          Overview

7.3.6.2          Neuraminidases - Revenue and Forecast to 2028 (US$ Million)

7.3.7        Others

7.3.7.1          Overview

7.3.7.2          Others- Revenue and Forecast to 2028 (US$ Million)

7.4         Instruments

7.4.1        Overview

7.4.2        Instruments - Revenue and Forecast to 2028 (US$ Million)

7.4.3        Mass Spectrometers

7.4.3.1          Overview

7.4.3.2          Mass Spectrometers- Revenue and Forecast to 2028 (US$ Million)

7.4.4        MALDI-TOF

7.4.4.1          Overview

7.4.4.2          MALDI-TOF - Revenue and Forecast to 2028 (US$ Million)

7.4.5        High-Performance Liquid Chromatography (HPLC)

7.4.5.1          Overview

7.4.5.2          High-Performance Liquid Chromatography (HPLC)- Revenue and Forecast to 2028 (US$ Million)

7.4.6        Lectin Arrays

7.4.6.1          Overview

7.4.6.2          Lectin Arrays- Revenue and Forecast to 2028 (US$ Million)

7.4.7        Antibody Arrays

7.4.7.1          Overview

7.4.7.2          Antibody Arrays - Revenue and Forecast to 2028 (US$ Million)

7.4.8        Others

7.4.8.1          Overview

7.4.8.2          Others- Revenue and Forecast to 2028 (US$ Million)

7.5         Kits

7.5.1        Overview

7.5.2        Kits - Revenue and Forecast to 2028 (US$ Million)

7.5.3        Glycan Release Kits

7.5.3.1          Overview

7.5.3.2          Glycan Release Kits - Revenue and Forecast to 2028 (US$ Million)

7.5.4        Glycan Labelling Kits

7.5.4.1          Overview

7.5.4.2          Glycan Labelling Kits - Revenue and Forecast to 2028 (US$ Million)

7.5.5        Glycan Purification Kits

7.5.5.1          Overview

7.5.5.2          Glycan Purification Kits - Revenue and Forecast to 2028 (US$ Million)

7.5.6        Others

7.5.6.1          Overview

7.5.6.2          Others- Revenue and Forecast to 2028 (US$ Million)

7.6         Reagents

7.6.1        Overview

7.6.2        Reagents - Revenue and Forecast to 2028 (US$ Million)

7.6.3        Oligosaccharides

7.6.3.1          Overview

7.6.3.2          Oligosaccharides- Revenue and Forecast to 2028 (US$ Million)

7.6.4        Monosaccharides

7.6.4.1          Overview

7.6.4.2          Monosaccharides - Revenue and Forecast to 2028 (US$ Million)

7.6.5        Glycoproteins

7.6.5.1          Overview

7.6.5.2          Glycoproteins - Revenue and Forecast to 2028 (US$ Million)

7.6.6        Others

7.6.6.1          Overview

7.6.6.2          Others- Revenue and Forecast to 2028 (US$ Million)

8.           Europe Glycomics Market Analysis – By Application

8.1         Overview

8.2         Europe Glycomics Market, By Application 2022 & 2028 (%)

8.3         Drug Discovery and Development

8.3.1        Overview

8.3.2        Drug Discovery and Development - Market Revenue and Forecast to 2028 (US$ Million)

8.4         Diagnostics

8.4.1        Overview

8.4.2        Diagnostics - Market Revenue and Forecast to 2028 (US$ Million)

8.5         Immunology

8.5.1        Overview

8.5.2        Immunology - Market Revenue and Forecast to 2028 (US$ Million)

8.6         Cancer

8.6.1        Overview

8.6.2        Cancer - Market Revenue and Forecast to 2028 (US$ Million)

8.7         Others

8.7.1        Overview

8.7.2        Others - Market Revenue and Forecast to 2028 (US$ Million)

9.           Europe Glycomics Market Analysis – By End User

9.1         Overview

9.2         Europe Glycomics Market, By End User 2022 & 2028 (%)

9.3         Pharmaceutical and Biotechnology Companies

9.3.1        Overview

9.3.2        Pharmaceutical and Biotechnology Companies - Market Revenue And Forecasts To 2028 (US$ Million)

9.4         Contract Research Organizations

9.4.1        Overview

9.4.2        Contract Research Organizations - Market Revenue And Forecasts To 2028 (US$ Million)

9.5         Academic and Research Institutes

9.5.1        Overview

9.5.2        Academic and Research Institutes - Market Revenue And Forecasts To 2028 (US$ Million)

10.        Europe Glycomics Market – Country Analysis

10.1      Overview

10.1.2     Europe: Glycomics Market, by Country, 2022 & 2028 (%)

10.1.2.1       Germany: Glycomics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.2.1.1       Overview

10.1.2.1.2       Germany: Glycomics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.2.1.3       Germany: Glycomics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

10.1.2.1.3.1    Germany: Glycomics Market Revenue and Forecasts to 2028, By Enzymes (US$ Million)

10.1.2.1.3.2    Germany: Glycomics Market Revenue and Forecasts to 2028, By Instruments (US$ Million)

10.1.2.1.3.3    Germany: Glycomics Market Revenue and Forecasts to 2028, By Kits (US$ Million)

10.1.2.1.3.4    Germany: Glycomics Market Revenue and Forecasts to 2028, By Reagents (US$ Million)

10.1.2.1.4       Germany: Glycomics Market, by Application– Revenue and Forecast to 2028 (US$ Million)

10.1.2.1.5       Germany: Glycomics Market, by End User– Revenue and Forecast to 2028 (US$ Million)

10.1.2.2       UK: Glycomics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.2.2.1       Overview

10.1.2.2.2       UK: Glycomics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.2.2.3       UK: Glycomics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

10.1.2.2.3.1    UK: Glycomics Market Revenue and Forecasts to 2028, By Enzymes (US$ Million)

10.1.2.2.3.2    UK: Glycomics Market Revenue and Forecasts to 2028, By Instruments (US$ Million)

10.1.2.2.3.3    UK: Glycomics Market Revenue and Forecasts to 2028, By Kits (US$ Million)

10.1.2.2.3.4    UK: Glycomics Market Revenue and Forecasts to 2028, By Reagents (US$ Million)

10.1.2.2.4       UK: Glycomics Market, by Application– Revenue and Forecast to 2028 (US$ Million)

10.1.2.2.5       UK: Glycomics Market, by End User– Revenue and Forecast to 2028 (US$ Million)

10.1.2.3       France: Glycomics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.2.3.1       Overview

10.1.2.3.2       France: Glycomics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.2.3.3       France: Glycomics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

10.1.2.3.3.1    France: Glycomics Market Revenue and Forecasts to 2028, By Enzymes (US$ Million)

10.1.2.3.3.2    France: Glycomics Market Revenue and Forecasts to 2028, By Instruments (US$ Million)

10.1.2.3.3.3    France: Glycomics Market Revenue and Forecasts to 2028, By Kits (US$ Million)

10.1.2.3.3.4    France: Glycomics Market Revenue and Forecasts to 2028, By Reagents (US$ Million)

10.1.2.3.4       France: Glycomics Market, by Application– Revenue and Forecast to 2028 (US$ Million)

10.1.2.3.5       France: Glycomics Market, by End User– Revenue and Forecast to 2028 (US$ Million)

10.1.2.4       Italy: Glycomics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.2.4.1       Overview

10.1.2.4.2       Italy: Glycomics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.2.4.3       Italy: Glycomics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

10.1.2.4.3.1    Italy: Glycomics Market Revenue and Forecasts to 2028, By Enzymes (US$ Million)

10.1.2.4.3.2    Italy: Glycomics Market Revenue and Forecasts to 2028, By Instruments (US$ Million)

10.1.2.4.3.3    Italy: Glycomics Market Revenue and Forecasts to 2028, By Kits (US$ Million)

10.1.2.4.3.4    Italy: Glycomics Market Revenue and Forecasts to 2028, By Reagents (US$ Million)

10.1.2.4.4       Italy: Glycomics Market, by Application– Revenue and Forecast to 2028 (US$ Million)

10.1.2.4.5       Italy: Glycomics Market, by End User– Revenue and Forecast to 2028 (US$ Million)

10.1.2.5       Spain: Glycomics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.2.5.1       Overview

10.1.2.5.2       Spain: Glycomics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.2.5.3       Spain: Glycomics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

10.1.2.5.3.1    Spain: Glycomics Market Revenue and Forecasts to 2028, By Enzymes (US$ Million)

10.1.2.5.3.2    Spain: Glycomics Market Revenue and Forecasts to 2028, By Instruments (US$ Million)

10.1.2.5.3.3    Spain: Glycomics Market Revenue and Forecasts to 2028, By Kits (US$ Million)

10.1.2.5.3.4    Spain: Glycomics Market Revenue and Forecasts to 2028, By Reagents (US$ Million)

10.1.2.5.4       Spain: Glycomics Market, by Application– Revenue and Forecast to 2028 (US$ Million)

10.1.2.5.5       Spain: Glycomics Market, by End User– Revenue and Forecast to 2028 (US$ Million)

10.1.2.6       Rest of Europe: Glycomics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.2.6.1       Overview

10.1.2.6.2       Rest of Europe: Glycomics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.2.6.3       Rest of Europe: Glycomics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

10.1.2.6.3.1    Rest of Europe: Glycomics Market Revenue and Forecasts to 2028, By Enzymes (US$ Million)

10.1.2.6.3.2    Rest of Europe: Glycomics Market Revenue and Forecasts to 2028, By Instruments (US$ Million)

10.1.2.6.3.3    Rest of Europe: Glycomics Market Revenue and Forecasts to 2028, By Kits (US$ Million)

10.1.2.6.3.4    Rest of Europe: Glycomics Market Revenue and Forecasts to 2028, By Reagents (US$ Million)

10.1.2.6.4       Rest of Europe: Glycomics Market, by Application– Revenue and Forecast to 2028 (US$ Million)

10.1.2.6.5       Rest of Europe: Glycomics Market, by End User– Revenue and Forecast to 2028 (US$ Million)

11.        Industry Landscape

11.1      Overview

11.2      Organic Developments

11.2.1     Overview

11.3      Inorganic Developments

11.3.1     Overview

12.        Company Profiles

12.1      MERCK KGaA

12.1.1     Key Facts

12.1.2     Business Description

12.1.3     Products and Services

12.1.4     Financial Overview

12.1.5     SWOT Analysis

12.1.6     Key Developments

12.2      Agilent Technologies, Inc.

12.2.1     Key Facts

12.2.2     Business Description

12.2.3     Products and Services

12.2.4     Financial Overview

12.2.5     SWOT Analysis

12.2.6     Key Developments

12.3      New England Biolabs

12.3.1     Key Facts

12.3.2     Business Description

12.3.3     Products and Services

12.3.4     Financial Overview

12.3.5     SWOT Analysis

12.3.6     Key Developments

12.4      Thermo Fisher Scientific Inc.

12.4.1     Key Facts

12.4.2     Business Description

12.4.3     Products and Services

12.4.4     Financial Overview

12.4.5     SWOT Analysis

12.4.6     Key Developments

12.5      Waters Corporation

12.5.1     Key Facts

12.5.2     Business Description

12.5.3     Products and Services

12.5.4     Financial Overview

12.5.5     SWOT Analysis

12.5.6     Key Developments

12.6      Asparia Glycomics

12.6.1     Key Facts

12.6.2     Business Description

12.6.3     Products and Services

12.6.4     Financial Overview

12.6.5     SWOT Analysis

12.6.6     Key Developments

12.7      Bruker Corporation

12.7.1     Key Facts

12.7.2     Business Description

12.7.3     Products and Services

12.7.4     Financial Overview

12.7.5     SWOT Analysis

12.7.6     Key Developments

12.8      Takara Bio Inc.

12.8.1     Key Facts

12.8.2     Business Description

12.8.3     Products and Services

12.8.4     Financial Overview

12.8.5     SWOT Analysis

12.8.6     Key Developments

12.9      S-BIO (Sumitomo Bakelite Co., Ltd.)

12.9.1     Key Facts

12.9.2     Business Description

12.9.3     Products and Services

12.9.4     Financial Overview

12.9.5     SWOT Analysis

12.9.6     Key Developments

12.10   Shimadzu Corporation

12.10.1  Key Facts

12.10.2  Business Description

12.10.3  Products and Services

12.10.4  Financial Overview

12.10.5  SWOT Analysis

12.10.6  Key Developments

13.        Appendix

13.1      About The Insight Partners

13.2      Glossary of Terms

 

 

LIST OF TABLES

Table 1.             Europe Glycomics Market, Revenue and Forecast, 2019–2028 (US$ Mn)

Table 2.             Germany: Glycomics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 3.             Germany: Glycomics Market Revenue and Forecasts to 2028, By Enzymes (US$ Million)

Table 4.             Germany: Glycomics Market Revenue and Forecasts to 2028, By Instruments (US$ Million)

Table 5.             Germany: Glycomics Market Revenue and Forecasts to 2028, By Kits (US$ Million)

Table 6.             Germany: Glycomics Market Revenue and Forecasts to 2028, By Reagents (US$ Million)

Table 7.             Germany: Glycomics Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 8.             Germany: Glycomics Market, by End User– Revenue and Forecast to 2028 (US$ Million)

Table 9.             UK: Glycomics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 10.          UK: Glycomics Market Revenue and Forecasts to 2028, By Enzymes (US$ Million)

Table 11.          UK: Glycomics Market Revenue and Forecasts to 2028, By Instruments (US$ Million)

Table 12.          UK: Glycomics Market Revenue and Forecasts to 2028, By Kits (US$ Million)

Table 13.          UK: Glycomics Market Revenue and Forecasts to 2028, By Reagents (US$ Million)

Table 14.          UK: Glycomics Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 15.          UK: Glycomics Market, by End User– Revenue and Forecast to 2028 (US$ Million)

Table 16.          France: Glycomics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 17.          France: Glycomics Market Revenue and Forecasts to 2028, By Enzymes (US$ Million)

Table 18.          France: Glycomics Market Revenue and Forecasts to 2028, By Instruments (US$ Million)

Table 19.          France: Glycomics Market Revenue and Forecasts to 2028, By Kits (US$ Million)

Table 20.          France: Glycomics Market Revenue and Forecasts to 2028, By Reagents (US$ Million)

Table 21.          France: Glycomics Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 22.          France: Glycomics Market, by End User– Revenue and Forecast to 2028 (US$ Million)

Table 23.          Italy: Glycomics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 24.          Italy: Glycomics Market Revenue and Forecasts to 2028, By Enzymes (US$ Million)

Table 25.          Italy: Glycomics Market Revenue and Forecasts to 2028, By Instruments (US$ Million)

Table 26.          Italy: Glycomics Market Revenue and Forecasts to 2028, By Kits (US$ Million)

Table 27.          Italy: Glycomics Market Revenue and Forecasts to 2028, By Reagents (US$ Million)

Table 28.          Italy: Glycomics Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 29.          Italy: Glycomics Market, by End User– Revenue and Forecast to 2028 (US$ Million)

Table 30.          Spain: Glycomics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 31.          Spain: Glycomics Market Revenue and Forecasts to 2028, By Enzymes (US$ Million)

Table 32.          Spain: Glycomics Market Revenue and Forecasts to 2028, By Instruments (US$ Million)

Table 33.          Spain: Glycomics Market Revenue and Forecasts to 2028, By Kits (US$ Million)

Table 34.          Spain: Glycomics Market Revenue and Forecasts to 2028, By Reagents (US$ Million)

Table 35.          Spain: Glycomics Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 36.          Spain: Glycomics Market, by End User– Revenue and Forecast to 2028 (US$ Million)

Table 37.          Rest of Europe: Glycomics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 38.          Rest of Europe: Glycomics Market Revenue and Forecasts to 2028, By Enzymes (US$ Million)

Table 39.          Rest of Europe: Glycomics Market Revenue and Forecasts to 2028, By Instruments (US$ Million)

Table 40.          Rest of Europe: Glycomics Market Revenue and Forecasts to 2028, By Kits (US$ Million)

Table 41.          Rest of Europe: Glycomics Market Revenue and Forecasts to 2028, By Reagents (US$ Million)

Table 42.          Rest of Europe: Glycomics Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 43.          Rest of Europe: Glycomics Market, by End User– Revenue and Forecast to 2028 (US$ Million)

Table 44.          Organic Developments in the Glycomics Market

Table 45.          Inorganic Developments in the Glycomics Market

Table 46.          Glossary of Terms

 

 

LIST OF FIGURES

Figure 1.           Europe Glycomics Market Segmentation

Figure 2.           Europe Glycomics Market, By Country

Figure 3.           Europe Glycomics Market Overview

Figure 4.           Europe Glycomics Market, By Product

Figure 5.           Europe Glycomics Market, By Country

Figure 6.           Europe: PEST Analysis

Figure 7.           Europe Glycomics Market Impact Analysis of Driver and Restraints

Figure 8.           Europe Glycomics Market – Revenue Forecast and Analysis

Figure 9.           Europe Glycomics Market, by Product 2022 & 2028 (%)

Figure 10.        Europe Enzymes Revenue and Forecasts to 2028 (US$ Million)

Figure 11.        Europe Glycosidases - Revenue and Forecasts to 2028 (US$ Million)

Figure 12.        Europe Glycosyltransferases - Revenue and Forecasts to 2028 (US$ Million)

Figure 13.        Europe Sialyltransferases - Revenue and Forecasts to 2028 (US$ Million)

Figure 14.        Europe Neuraminidases - Revenue and Forecasts to 2028 (US$ Million)

Figure 15.        Europe Others - Revenue and Forecasts to 2028 (US$ Million)

Figure 16.        Europe Instruments - Revenue and Forecasts to 2028 (US$ Million)

Figure 17.        Europe Mass Spectrometers - Revenue and Forecasts to 2028 (US$ Million)

Figure 18.        Europe MALDI-TOF - Revenue and Forecasts to 2028 (US$ Million)

Figure 19.        Europe High-Performance Liquid Chromatography (HPLC)- Revenue and Forecasts to 2028 (US$ Million)

Figure 20.        Europe Lectin Arrays - Revenue and Forecasts to 2028 (US$ Million)

Figure 21.        Europe Antibody Arrays - Revenue and Forecasts to 2028 (US$ Million)

Figure 22.        Europe Others - Revenue and Forecasts to 2028 (US$ Million)

Figure 23.        Europe Kits - Revenue and Forecasts to 2028 (US$ Million)

Figure 24.        Europe Glycan Release Kits - Revenue and Forecasts to 2028 (US$ Million)

Figure 25.        Europe Glycan Labelling Kits - Revenue and Forecasts to 2028 (US$ Million)

Figure 26.        Europe Glycan Purification Kits - Revenue and Forecasts to 2028 (US$ Million)

Figure 27.        Europe Others - Revenue and Forecasts to 2028 (US$ Million)

Figure 28.        Europe Reagents - Revenue and Forecasts to 2028 (US$ Million)

Figure 29.        Europe Oligosaccharides - Revenue and Forecasts to 2028 (US$ Million)

Figure 30.        Europe Monosaccharides - Revenue and Forecasts to 2028 (US$ Million)

Figure 31.        Europe Glycoproteins - Revenue and Forecasts to 2028 (US$ Million)

Figure 32.        Europe Others - Revenue and Forecasts to 2028 (US$ Million)

Figure 33.        Europe Glycomics Market, by Application 2022 & 2028 (%)

Figure 34.        Europe Drug Discovery and Development - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 35.        Europe Diagnostics - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 36.        Europe Immunology - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 37.        Europe Cancer - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 38.        Europe Others - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 39.        Europe Glycomics Market, by End User 2022 & 2028 (%)

Figure 40.        Europe Pharmaceutical and Biotechnology Companies - Market Revenue And Forecasts To 2028 (US$ Million)

Figure 41.        Europe Contract Research Organizations - Market Revenue And Forecasts To 2028 (US$ Million)

Figure 42.        Europe Academic and Research Institutes - Market Revenue And Forecasts To 2028 (US$ Million)

Figure 43.        Europe: Glycomics Market, by Key Country – Revenue (2022) (US$ Million)

Figure 44.        Europe: Glycomics Market, by Country, 2022 & 2028 (%)

Figure 45.        Germany: Glycomics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 46.        UK: Glycomics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 47.        France: Glycomics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 48.        Italy: Glycomics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 49.        Spain: Glycomics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 50.        Rest of Europe: Glycomics Market – Revenue and Forecast to 2028 (US$ Million)

  1. Agilent Technologies, Inc.
  2. Asparia Glycomics
  3. Bruker Corporation
  4. MERCK KGaA
  5. New England Biolabs
  6. S-BIO (Sumitomo Bakelite Co., Ltd.)
  7. Shimadzu Corporation
  8. Takara Bio Inc.
  9. Thermo Fisher Scientific Inc.
  10. Waters Corporation    
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe glycomics market.      
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the Europe glycomics market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the glycomics market, as well as those hindering it 
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution  

 

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3000
$2400
Site License
$4000
$3200
Enterprise License
$5000
$4000